An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients

L M E Grimaldi1, A Pincherle, F Martinelli-Boneschi

  • 1Department of Neurosciences, AUSL 2 Caltanissetta, Via G. Cusmano 3, 93100 Caltanissetta, Italy. luigi.grimaldi@hsr.it

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 30, 2003
PubMed

Insights

Chlamydia pneumoniae infection in cerebrospinal fluid was detected in 21.5% of multiple sclerosis patients, suggesting a potential role in disease activity and progression. This finding may impact the course of multiple sclerosis in affected individuals.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Neurology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS).
  • The role of infectious agents in MS pathogenesis remains an area of active investigation.
  • Chlamydia pneumoniae (CP) is a bacterium with a potential link to neurological disorders.

Purpose of the Study:

  • To investigate the presence of Chlamydia pneumoniae in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients.
  • To explore the association between CP detection and disease activity and progression in MS.

Main Methods:

  • Amplification of Chlamydia pneumoniae major-outer membrane protein sequences in CSF samples.
  • Comparison of CP detection rates between MS patients and patients with other neurological diseases (OND).
  • Correlation analysis between CP positivity and MRI-defined disease activity, age at onset, and disease duration in MS patients.

Main Results:

  • Chlamydia pneumoniae DNA was detected in the CSF of 21.5% of MS patients versus 2.6% of OND patients (P = 0.00022).
  • CP-positive MS patients exhibited significantly more active disease on MRI (P = 0.02).
  • CP positivity was associated with a trend towards earlier age at disease onset and a significantly longer disease duration (P = 0.016).

Conclusions:

  • The findings indirectly suggest that Chlamydia pneumoniae infection of the CNS may influence the disease course in a subset of multiple sclerosis patients.
  • CP infection could be a contributing factor to disease activity and progression in multiple sclerosis.
  • Further research is warranted to elucidate the direct causal relationship between CP and MS.